Key drivers for each region include: for North America, high demographics of aging population, advanced infrastructure, and mature ecosystem; for Europe, increasing adoption of EMG electrodes in neurological disorders, stringent policies regulating medical devices, and significant investments in research and development; for Asia Pacific, growing demand for EMG electrodes in emerging economies, rising awareness about neurological disorders, and expanding distribution networks; for Latin America, increasing adoption of EMG electrodes in Brazil and Mexico, improving infrastructure, and government policies supporting healthcare development; and for Middle East & Africa, growing demand for EMG electrodes in the Gulf Cooperation Council (GCC) countries, rising awareness about neurological disorders, and increasing investments in healthcare infrastructure.